EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 115 filers reported holding EPIZYME INC in Q3 2019. The put-call ratio across all filers is 0.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $332,000 | -17.8% | 32,192 | 0.0% | 0.04% | +50.0% |
| Q2 2019 | $404,000 | -82.1% | 32,192 | -82.3% | 0.03% | -73.1% |
| Q1 2019 | $2,253,000 | +0.9% | 181,900 | -49.8% | 0.10% | -32.5% |
| Q4 2018 | $2,233,000 | +274.0% | 362,600 | +722.2% | 0.15% | +340.0% |
| Q2 2018 | $597,000 | +0.8% | 44,100 | -6.6% | 0.04% | +9.4% |
| Q4 2017 | $592,000 | +175.3% | 47,200 | +230.1% | 0.03% | +146.2% |
| Q2 2017 | $215,000 | -54.4% | 14,300 | -70.2% | 0.01% | -65.8% |
| Q3 2016 | $472,000 | -86.1% | 48,000 | -85.5% | 0.04% | -88.0% |
| Q2 2016 | $3,392,000 | -15.5% | 331,300 | 0.0% | 0.32% | -21.9% |
| Q1 2016 | $4,015,000 | +15.5% | 331,300 | +52.6% | 0.41% | -8.4% |
| Q4 2015 | $3,477,000 | +15.9% | 217,100 | -7.1% | 0.44% | +13.6% |
| Q3 2015 | $3,001,000 | – | 233,600 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
| Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
| Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
| MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
| Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
| Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
| Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
| Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
| Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
| Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |